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Letters to the editor
‘Facial naevus flammeus with choroidal haemangioma and
without intracranial involvement’
SIR–We would like to report a male patient who was noted
at birth to have left-sided facial naevus flammeus (port wine
stain) involving the left side of the scalp, upper eyelid, and
the left side of the nose. Follow-up in the next 6 years did
not show any developmental problems, focal neurological
deficit, nor seizures. His left eye was found to be hyper-
aemic over the bulbar conjunctiva. He also had ani-
sometropic hyperoptic astigmatism of the left eye. Fundal
examination confirmed the presence of left choroidal hae-
mangioma, mainly in the upper half and posterior pole of
the choroid. It was a well circumscribed lesion, slightly
raised, bright red in colour, and affecting the left foveal
region. The child had no evidence of raised intraocular
pressure. The latest follow-up assessment at 6 years record-
ed visual acuity of 6/5(right eye) and 6/9 (left eye) with
glasses correction. He is currently undergoing treatment
for left amblyopia. 
At 18 months of age the child had brain CT which was nor-
mal. To clarify the diagnosis further, and to be in a position to
give the parents an accurate diagnosis and prognosis, MRI
was performed at the age of 6 years. Brain imaging enhanced
by gadalinium – DTPA was performed. This showed diffuse
enhancement of the choroid with choroidal angioma of the
left eye. There was no intracranial abnormality. 
Naevus flammeus can be an isolated birthmark or it can
be associated with ophthalmological and/or neurological
abnormalities. When neurological abnormalities are present
the diagnosis of Sturge-Weber syndrome (SWS) is highly like-
ly. Stevenson and colleagues reported ocular findings in 50
patients with naevus flammeus.1,2 Only one patient was
found to have clinical evidence of choroidal haemangioma
and this patient did not have intracranial abnormalities.
Sullivan and coworkers reported the ocular manifestations of
SWS in 51 patients. Of these, 28 had choroidal haemangiomas.3
Choroidal haemangiomas in SWS patients are usually dif-
fuse, primarily related to the posterior pole, and usually
seen as red, flat to moderately elevated masses. This is in
contrast to choroidal haemangiomas not associated with
SWS which are usually discreet raised structures arising
from the choroid.4 In our patient, the naevus flammeus
involves the ophthalmic and maxillary divisions of the
trigeminal nerve and the choroidal haemangioma has the
characteristics of those seen in SWS. However, the child
does not have any neurological deficit. 
We feel it is appropriate in these cases to clarify the possi-
bility of intracranial involvement with neuroimaging to be
able to give parents an accurate prognosis.
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‘Salivary cortisol in children with cognitive impairment’
SIR–Cortisol plays an essential role in stress-regulation in
humans.1 It is produced in a well-defined circadian rhythm
which is under the influence of an individual’s sleep–wake
activity. Under basal conditions, cortisol levels are highest in
the early morning and subsequently decrease, reaching a
minimum level after midnight. Gunnar and colleagues have
provided evidence that in healthy children the cortisol circa-
dian rhythm should be present at 15 months of age.2
Rises in cortisol levels may be a useful indicator that a per-
son is experiencing pain.3 This may be especially helpful in
children with profound cognitive impairment (PCI) who
may be unable to express themselves verbally.4 To be able to
recognize and interpret changes in cortisol levels in reaction
to stressful events, the availability of reference values for
stress- and pain-free children is essential. These reference
values are available for normally developed, healthy chil-
dren5 but it is not known whether they are comparable with
the levels typical of children with PCI and can, therefore, be
used as normative data in studies of such children. Given the
numerous, potentially painful events that can occur in chil-
dren with PCI, and the almost complete lack of well-validat-
ed pain measures, these baseline data are urgently needed.
The aim of this study was to provide baseline cortisol levels
for children with PCI and compare them with levels in chil-
dren without cognitive impairment. The medical ethical com-
mittee of the hospital approved this study and informed
consent was obtained from parents of participating children. 
There are two important reasons why diurnal cortisol levels
in children with PCI may be disturbed. First, children with PCI
usually have many physical problems. Second, although
empirical evidence is lacking, clinical impressions indicate that
children with PCI tend to show disturbed sleep behaviour. 
Using a cross-sectional design, saliva samples were collect-
ed at 7.30, 12.30, and 17.30 in 49 children (29 males, 20
females; age range 1 to 18 years) with PCI and in 44 age- and
sex-matched children without cognitive impairment. Origins
of the cognitive impairment in the children with PCI were
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documented (Table I). Cortisol levels were determined by
radioimmunoassay. Interassay variation was below 14%,
whereas intra-assay variations were between 5 and 7%, with
the exception of samples with cortisol levels below 2nmol/L,
where it was 16%. Sensitivity of the assay was 0.8nmol/l.
For both groups of children in this study, possible con-
founders of the measured cortisol levels were noted. Use of
medication, especially analgesics and anticonvulsants,6 was
evaluated for both groups because of its influence on cortisol
production. Thirty-nine children (41.9%; all cognitively
impaired) had mild to severe epilepsy for which they were
treated with a wide variety of anticonvulsant drugs. However,
no stressful events or overt epileptic features occurred within
the 2 hours before sampling. None of the children used anal-
gesics on a regular basis nor used them on the day of sampling. 
The Mann-Whitney U test (p<0.05) was used to compare
median cortisol levels in saliva from the children with and
without cognitive impairment. Fisher’s exact test (p<0.05)
was performed to investigate whether the difference in lack
of a circadian rhythm in both groups was statistically signifi-
cant. In order to test if children with cognitive impairment
with and without a circadian rhythm of cortisol differed in
clinical, physiological, or sociographic parameters, a Mann-
Whitney U test was performed.
Cortisol levels and their circadian variation in children
with cognitive impairment were not significantly different
from those of children without cognitive impairment,
although across all measurements the median cortisol levels
for the cognitively impaired children were on average 0.5
nmol/L higher and showed more variation. When looking at
the intra-individual variation of cortisol levels, in more than
one third of the impaired children (40.8%) and in almost
one third of the children without cognitive impairment
(31.8%), a circadian rhythm was lacking. However, this dif-
ference did not reach statistical significance. Despite analy-
sis of possible confounding variables, no explanation for the
absence of a circadian rhythm was found. Technical prob-
lems such as the sensitivity threshold of cortisol levels were
ruled out.  
Our results indicate that reference values of salivary cortisol
in normally developed, healthy children can also be used for
children with PCI. These data contain baseline, stress-free cor-
tisol levels in children with PCI which can be used as a refer-
ence. In this way it is feasible to try and detect distress, or pain
by measuring salivary cortisol levels in children with PCI in
conjunction with pain assessment instruments developed for
this group of children.7 We are currently studying postsurgical
cortisol levels of these children in order to gain insight into the
relationship between salivary cortisol concentrations and non-
verbal behaviour during painful episodes. 
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Table I: Origin of cognitive impairment (n=49)
Origin of cognitive impairment n % 
Congenital/metabolic anomalies
Syndrome 9 18.4
Infections 2 4.1
Major structural cerebral abnormalities 5 10.2
Total 16 32.7
Cognitive  impairment during birth
Perinatal asphyxia 7 14.3
Posthypoxic encephalopathy 5 10.2
Total 12 24.5
Cognitive  impairment after birth
(2 months – 2 years of age)
Encephalopathy  11 22.4
Myocardial infarct 1 2
Meningo- or pneumococcal sepsis 5 10.2
Total 17 34.6
Origin remained unknown
Total 4 8.2
